Biophysical characterization of influenza virus subpopulations using field flow fractionation and multiangle light scattering: Correlation of particle counts, size distribution and infectivity

被引:87
作者
Wei, Ziping [1 ]
Mcevoy, Matt
Razinkov, Vladimir
Polozova, Alla
Li, Elizabeth
Casas-Finet, Jose
Tous, Guillermo I.
Balu, Palani
Pan, Alfred A.
Mehta, Harshvardhan
Schenerman, Mark A.
机构
[1] Medimmune Inc, Gaithersburg, MD 20878 USA
[2] Medimmune Vaccines, Mountain View, CA 94043 USA
关键词
influenza virus; field flow fractionation; multiangle light scattering; size exclusion chromatography; atomic force microscopy; aggregation;
D O I
10.1016/j.jviromet.2007.04.008
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Adequate biophysical characterization of influenza virions is important for vaccine development. The influenza virus vaccines are produced from the allantoic fluid of developing chicken embryos. The process of viral replication produces a heterogeneous mixture of infectious and non-infectious viral particles with varying states of aggregation. The study of the relative distribution and behavior of different subpopulations and their inter-correlation can assist in the development of a robust process for a live virus vaccine. This report describes a field flow fractionation and multiangle light scattering (FFF-MALS) method optimized for the analysis of size distribution and total particle counts. The FFF-MALS method was compared with several other methods such as transmission electron microscopy (TEM), atomic force microscopy (AFM), size exclusion chromatography followed by MALS (SEC-MALS), quantitative reverse transcription polymerase chain reaction (RT Q-PCR), median tissue culture dose (TCID50), and the fluorescent focus assay (FFA). The correlation between the various methods for determining total particle counts, infectivity and size distribution is reported. The pros and cons of each of the analytical methods are discussed. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:122 / 132
页数:11
相关论文
共 33 条
[1]  
BALCH WM, 2002, J VIROL, V76, P7133
[2]   Evidence for segment-nonspecific packaging of the influenza A virus genome [J].
Bancroft, CT ;
Parslow, TG .
JOURNAL OF VIROLOGY, 2002, 76 (14) :7133-7139
[3]   COLD-RECOMBINANT INFLUENZA-A CALIFORNIA/10/78 (H1N1) VIRUS-VACCINE (CR-37) IN SERONEGATIVE CHILDREN - INFECTIVITY AND EFFICACY AGAINST INVESTIGATIONAL CHALLENGE [J].
BELSHE, RB ;
VANVORIS, LP .
JOURNAL OF INFECTIOUS DISEASES, 1984, 149 (05) :735-740
[4]  
Bondoc LL, 1998, J IND MICROBIOL BIOT, V20, P317
[5]   ISOLATION OF INFLUENZA VIRAL-PROTEINS BY SIZE-EXCLUSION AND ION-EXCHANGE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY - THE INFLUENCE OF CONDITIONS ON SEPARATION [J].
CALAM, DH ;
DAVIDSON, J .
JOURNAL OF CHROMATOGRAPHY, 1984, 296 (JUL) :285-292
[6]   Structural changes and aggregation of human influenza virus [J].
Campbell, JN ;
Epand, RM ;
Russo, PS .
BIOMACROMOLECULES, 2004, 5 (05) :1728-1735
[7]   Cold-adapted poliovirus mutants bypass a postentry replication block [J].
Dove, AW ;
Racaniello, VR .
JOURNAL OF VIROLOGY, 1997, 71 (06) :4728-4735
[8]   AN INFLUENZA-VIRUS CONTAINING 9 DIFFERENT RNA SEGMENTS [J].
ENAMI, M ;
SHARMA, G ;
BENHAM, C ;
PALESE, P .
VIROLOGY, 1991, 185 (01) :291-298
[9]   Nanovector therapeutics [J].
Ferrari, M .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2005, 9 (04) :343-346
[10]   The use of asymmetrical flow field-flow fractionation in pharmaceutics and biopharmaceutics [J].
Fraunhofer, W ;
Winter, G .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2004, 58 (02) :369-383